Starpharma Holdings Ltd (SPHRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 3,789 | 6,398 | 2,833 | 3,554 | 2,606 |
| Cost of Goods | 793 | 415 | 754 | 2,014 | 591 |
| Gross Profit | 2,996 | 5,984 | 2,079 | 1,540 | 2,015 |
| Operating Expenses | 10,258 | 11,753 | 13,360 | 13,465 | 17,349 |
| Operating Income | -6,470 | -5,355 | -10,528 | -11,911 | -14,744 |
| Interest Expense | 0 | 0 | 0 | -191 | 0 |
| Pre-tax Income | -6,470 | -5,355 | -10,528 | -11,720 | -14,744 |
| Net Income Continuous | -6,470 | -5,355 | -10,528 | -11,720 | -14,744 |
| Net Income | $-6,470 | $-5,355 | $-10,528 | $-11,720 | $-14,744 |
| EPS Basic Total Ops | -0.13 | -0.13 | -0.27 | -0.29 | -0.37 |
| EPS Basic Continuous Ops | -0.16 | -0.13 | -0.26 | -0.29 | -0.37 |
| EPS Diluted Total Ops | -0.13 | -0.13 | -0.27 | -0.29 | -0.37 |
| EPS Diluted Continuous Ops | -0.16 | -0.13 | -0.26 | -0.29 | -0.37 |
| EPS Diluted Before Non-Recurring Items | -0.13 | -0.13 | -0.27 | -0.29 | -0.37 |
| EBITDA(a) | $-5,777 | $-4,623 | $-9,724 | $-11,128 | $-14,045 |